0001127602-21-019510.txt : 20210609 0001127602-21-019510.hdr.sgml : 20210609 20210609160600 ACCESSION NUMBER: 0001127602-21-019510 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210608 FILED AS OF DATE: 20210609 DATE AS OF CHANGE: 20210609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Timothy Eugene CENTRAL INDEX KEY: 0001707000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 211005199 MAIL ADDRESS: STREET 1: 800 BOYLSTON ST., SUITE 3310 STREET 2: PRUDENTIAL TOWER C/O AJU IB INVESTMENT CITY: BOSTON STATE: MA ZIP: 02199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-06-08 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001707000 Sullivan Timothy Eugene C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Chief Financial Officer Common Stock 2021-06-08 4 M 0 39880 10.03 A 74141 D Stock Option (Right to Buy) 10.03 2021-06-08 4 M 0 39880 0 D 2027-10-19 Common Stock 39880 358619 D This option was granted on October 18, 2017 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service. /s/ David Watson as attorney-in-fact for Timothy Sullivan 2021-06-09